| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 30/11/2016 | 22:25 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 30/11/2016 | 22:16 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 23/11/2016 | 23:28 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 23/11/2016 | 19:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 08/11/2016 | 22:18 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 28/10/2016 | 12:11 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 26/10/2016 | 22:17 | Edgar (US Regulatory) | Proxy Soliciting Materials (revised) (prer14a) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 23/09/2016 | 13:53 | PR Newswire (US) | Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan... | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 12/09/2016 | 19:38 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 24/08/2016 | 12:02 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (preliminary) (prem14a) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 24/06/2016 | 22:19 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 24/06/2016 | 22:18 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 22/06/2016 | 22:00 | GlobeNewswire Inc. | Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed Transaction | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 15/06/2016 | 13:30 | GlobeNewswire Inc. | Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share Purchase Agreement | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 01/06/2016 | 19:14 | Business Wire | Robbins Arroyo LLP is Investigating the Officers and Directors of Carbylan Therapeutics, Inc. (CBYL) on Behalf of Shareholders | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 21/05/2016 | 02:01 | PR Newswire (US) | Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; NewLink Genetics Corporation, DeVry Education ... | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 28/04/2016 | 22:19 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 15/04/2016 | 22:48 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 15/04/2016 | 13:30 | GlobeNewswire Inc. | Carbylan Therapeutics Announces Decision to Pursue Strategic Transaction | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 01/04/2016 | 17:26 | Business Wire | INVESTOR ALERT: Investigation of Carbylan Therapeutics, Inc. Announced by Law Offices of Howard G. Smith, Encourages Investor... | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 30/03/2016 | 22:15 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 25/03/2016 | 17:51 | PR Newswire (US) | Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; La Quinta Holdings Inc., DS Healthcare Group, ... | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 24/03/2016 | 15:30 | Business Wire | Investor Alert: Glancy Prongay & Murray LLP Commences Investigation on Behalf of Carbylan Therapeutics, Inc. Investors | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 22/03/2016 | 19:15 | Business Wire | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud V... | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 22/03/2016 | 17:32 | PR Newswire (US) | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Carbylan Therapeutics, Inc. (CBYL) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 21/03/2016 | 23:18 | Business Wire | Robbins Arroyo LLP Is Investigating the Officers and Directors of Carbylan Therapeutics, Inc. (CBYL) on Behalf of Shareholders | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 17/03/2016 | 21:15 | GlobeNewswire Inc. | Carbylan Therapeutics Engages Wedbush PacGrow to Advise on Strategic Alternatives | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 16/03/2016 | 13:10 | PR Newswire (US) | Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Carbylan Ther... | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 04/02/2016 | 19:42 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |
| 01/02/2016 | 22:01 | GlobeNewswire Inc. | Carbylan Therapeutics Reports Top-Line Results From COR1.1 Clinical Trial of Hydros-TA in Patients With OA of the Knee | NASDAQ:CBYL | Kalvista Pharmaceuticals (MM) |